UCSF researchers move closer to predicting sudden infant death syndrome

Researchers at UC San Francisco are getting closer to being able to predict sudden infant death syndrome, or SIDS.

Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine

What You Should Know: – Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with

October 30, 2024

Hoth and Aronnax partner for HT-KIT cancer therapy development

Research revealed that a single dose of the product can have an effect lasting approximately two weeks, with reduced KIT expression. Credit: Kmpzzz via Shutterstock.

August 16, 2024

Pioneering study brings leishmaniasis vaccine development closer

Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.